Royal Bank of Canada’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-25,030
| Closed | -$251K | – | 7187 |
|
|
2023
Q4 | $251K | Buy |
25,030
+25,000
| +83,333% | +$251K | ﹤0.01% | 4393 |
|
|
2023
Q3 | $0 | Hold |
30
| – | – | ﹤0.01% | 7192 |
|
|
2023
Q2 | $0 | Sell |
30
-85
| -74% | – | ﹤0.01% | 7258 |
|
|
2023
Q1 | $0 | Buy |
115
+70
| +156% | – | ﹤0.01% | 7072 |
|
|
2022
Q4 | $0 | Sell |
45
-62
| -58% | – | ﹤0.01% | 7341 |
|
|
2022
Q3 | $0 | Sell |
107
-1,493
| -93% | – | ﹤0.01% | 7450 |
|
|
2022
Q2 | $9K | Buy |
+1,600
| New | +$9K | ﹤0.01% | 5974 |
|